{"disease":{"id":"diabetic-neuropathy","name":"Diabetic neuropathy","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":1},"drugs":{"marketed":[{"drug_id":"mirogabalin","indication_name":"Diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tarlige","generic_name":"MIROGABALIN","company_name":"Daiichi Sankyo","drug_phase":"marketed","molecular_target":"Voltage-dependent calcium channel subunit alpha-2/delta-1","drug_class":"","quality_score":35,"revenue":"300","mechanism":""},{"drug_id":"lyrica","indication_name":"Neuropathic pain associated with diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"lyrica","indication_name":"Neuropathic pain associated with diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lyrica","generic_name":"Pregabalin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"alpha-2-delta subunit (auxiliary subunit of voltage-gated calcium channels)","drug_class":"Anticonvulsant, analgesic","quality_score":10,"revenue":null,"mechanism":"Pregabalin binds alpha-2-delta subunit of voltage-gated calcium channels in CNS."},{"drug_id":"duloxetine","indication_name":"Diabetic peripheral neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cymbalta","generic_name":"duloxetine","company_name":"Eli Lilly and Company","drug_phase":"marketed","molecular_target":"Serotonin and norepinephrine reuptake","drug_class":"Serotonin and norepinephrine reuptake inhibitor (SNRI)","quality_score":68,"revenue":null,"mechanism":"Potentiates serotonergic and noradrenergic activity in the CNS through unknown exact mechanisms."},{"drug_id":"epalrestat","indication_name":"Diabetic neuropathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Eabeth","generic_name":"EPALRESTAT","company_name":"","drug_phase":"marketed","molecular_target":"Aldose reductase","drug_class":"epalrestat","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"bat","indication_name":"Treatment of neuropathic pain associated with diabetic peripheral neuropathy in adults","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bat","generic_name":"bat","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Unknown","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":6,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05043636","title":"Diabetic Neuropathy Screening Study 1.1 + Substudy 1.2-1.3-1.4","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Steno Diabetes Center Copenhagen","has_results":false},{"nct_id":"NCT03520608","title":"Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT06041399","title":"The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":1400,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT06041412","title":"The Effect of Related Blood Markers on Diabetic Peripheral Neuropathy","phase":"","overall_status":"UNKNOWN","enrollment_count":1400,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT06546202","title":"Real-World Pharmacological Treatment Pattern of Neuropathic Pain in China","phase":"","overall_status":"COMPLETED","enrollment_count":1271,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT03440203","title":"Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":975,"lead_sponsor_name":"Okayama University","has_results":false},{"nct_id":"NCT05754190","title":"Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"Brown University","has_results":false},{"nct_id":"NCT01057693","title":"Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":633,"lead_sponsor_name":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","has_results":true},{"nct_id":"NCT01713426","title":"A Study to Compare QUTENZA With Pregabalin for the Treatment of Peripheral Neuropathic Pain (PNP) After 8 Weeks of Treatment","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":568,"lead_sponsor_name":"Astellas Pharma Europe Ltd.","has_results":false},{"nct_id":"NCT06072573","title":"Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":558,"lead_sponsor_name":"Apurano Pharmaceuticals GmbH","has_results":false},{"nct_id":"NCT06071975","title":"Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":558,"lead_sponsor_name":"Apurano Pharmaceuticals GmbH","has_results":false},{"nct_id":"NCT00350103","title":"A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":551,"lead_sponsor_name":"UCB Pharma","has_results":true},{"nct_id":"NCT06191614","title":"DEXINEURO® Tab on Blood Glucose Reduction in Patients With Type 2 Diabetes Accompanied by Diabetic Peripheral Neuropathy","phase":"","overall_status":"COMPLETED","enrollment_count":528,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT06040567","title":"Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study","phase":"","overall_status":"RECRUITING","enrollment_count":520,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05319275","title":"Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":516,"lead_sponsor_name":"Haisco Pharmaceutical Group Co., Ltd.","has_results":false},{"nct_id":"NCT04119167","title":"Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Chang Gung Memorial Hospital","has_results":false},{"nct_id":"NCT07117942","title":"FDGL Dose-Finding Study for Diabetic Neuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":485,"lead_sponsor_name":"Helwan University","has_results":false},{"nct_id":"NCT01496365","title":"Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"Daiichi Sankyo","has_results":true},{"nct_id":"NCT05299918","title":"Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan","phase":"","overall_status":"COMPLETED","enrollment_count":437,"lead_sponsor_name":"Istanbul University","has_results":false},{"nct_id":"NCT03228420","title":"Comparison of 10 kHz SCS Combined With CMM to CMM Alone in the Treatment of Neuropathic Limb Pain","phase":"NA","overall_status":"UNKNOWN","enrollment_count":430,"lead_sponsor_name":"Nevro Corp","has_results":true},{"nct_id":"NCT06074562","title":"A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":405,"lead_sponsor_name":"Eli Lilly and Company","has_results":false},{"nct_id":"NCT06432270","title":"Effect of Diabetes Mellitus on Cardiac Autonomic Function in Surgical Patients Undergoing General Anesthesia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":388,"lead_sponsor_name":"Zhujiang Hospital","has_results":false},{"nct_id":"NCT00220337","title":"A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":371,"lead_sponsor_name":"UCB Pharma","has_results":true},{"nct_id":"NCT06383702","title":"A Study to Evaluate Pregabalin in Painful Diabetic Peripheral Neuropathy","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":358,"lead_sponsor_name":"CSPC Ouyi Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04455633","title":"Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":319,"lead_sponsor_name":"Lexicon Pharmaceuticals","has_results":true},{"nct_id":"NCT03219320","title":"Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Aptinyx","has_results":true},{"nct_id":"NCT04638556","title":"Effect of Circulating lncRNAs on Type 2 Diabetic Peripheral Neuropathy","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Jinshan Hospital Fudan University","has_results":false},{"nct_id":"NCT07005947","title":"Long COVID-19 Cutaneous Signatures: An ARPA Funded Research Project","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":300,"lead_sponsor_name":"CND Life Sciences","has_results":false},{"nct_id":"NCT05783700","title":"Identification of Biomarkers for the Study of the Diabetic Foot and Evolution.","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Esther Soler","has_results":false},{"nct_id":"NCT04238208","title":"The Efficacy and Safety Profile of Capsaicin 8% Patch Versus 5% Lidocaine Patch in Males With Diabetic Neuropathy","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Corporacion Parc Tauli","has_results":false},{"nct_id":"NCT06483620","title":"Cross-cultural Adaptation and Validity of the Arabic-translated NEUROPATHY-SPECIFIC QUALITY OF LIFE Questionnaire","phase":"","overall_status":"RECRUITING","enrollment_count":290,"lead_sponsor_name":"Cairo University","has_results":false},{"nct_id":"NCT03176472","title":"Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":282,"lead_sponsor_name":"Regenacy Pharmaceuticals LLC","has_results":true},{"nct_id":"NCT07195045","title":"Thai PainPREDICT Validation Study","phase":"NA","overall_status":"RECRUITING","enrollment_count":277,"lead_sponsor_name":"Chulalongkorn University","has_results":false},{"nct_id":"NCT04246619","title":"Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life","phase":"PHASE4","overall_status":"TERMINATED","enrollment_count":254,"lead_sponsor_name":"KRKA","has_results":false},{"nct_id":"NCT03749642","title":"Trazodone/Gabapentin Fixed Dose Combination Products in Painful Diabetic Neuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Aziende Chimiche Riunite Angelini Francesco S.p.A","has_results":false},{"nct_id":"NCT04054076","title":"10 Years Follow-up Study of Plantar Pressure, Kinetics and Kinematics in a Cohort of Patients Diagnosed With Diabetes","phase":"NA","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Sahlgrenska University Hospital","has_results":false},{"nct_id":"NCT05080530","title":"Vitamin D and Painful Diabetic Neuropathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":216,"lead_sponsor_name":"Baqai Institute of Diabetology and Endocrinology","has_results":false},{"nct_id":"NCT05546138","title":"Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Aalborg University Hospital","has_results":false},{"nct_id":"NCT06124586","title":"Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT03356041","title":"The Role of a Clinical Pharmacist in Lifestyle Modification in Type 2 Diabetic Patients With Peripheral Neuropathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Hawler Medical University","has_results":false},{"nct_id":"NCT02402361","title":"Understanding Risk Factors and Determinants for Neuropathic Pain","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Rambam Health Care Campus","has_results":false},{"nct_id":"NCT04543422","title":"Green Tea Extracts for Mild-to-moderate Diabetic Peripheral Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Egyptian Biomedical Research Network","has_results":false},{"nct_id":"NCT03983200","title":"Effect of Rotating Magnetic Therapy on Diabetic Peripheral Neuropathy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Majianhua","has_results":false},{"nct_id":"NCT05660538","title":"Evaluation of Efficacy and Safety of VX-548 for Painful Diabetic Peripheral Neuropathy (DPN)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":194,"lead_sponsor_name":"Vertex Pharmaceuticals Incorporated","has_results":true},{"nct_id":"NCT03455543","title":"Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":182,"lead_sponsor_name":"Regenesis Biomedical, Inc.","has_results":true},{"nct_id":"NCT06734143","title":"High Diagnostic Performance of the Indicator Plaster Neuropad for the Detection of Diabetic Autonomic Neuropathy","phase":"","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Aristotle University Of Thessaloniki","has_results":false},{"nct_id":"NCT01564459","title":"Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":170,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07436585","title":"CGM-Guided Acarbose for Painful Diabetic Neuropathy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":170,"lead_sponsor_name":"Shifa International Hospital","has_results":false},{"nct_id":"NCT04688671","title":"Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Eliem Therapeutics (UK) Ltd.","has_results":true},{"nct_id":"NCT04469270","title":"Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":162,"lead_sponsor_name":"Helixmith Co., Ltd.","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}